Summary of Key Points Core Viewpoint - On October 15, 2025, Jinhao Medical (920925) closed at 34.05 yuan, down 3.81%, with a turnover rate of 2.78% and a trading volume of 15,400 shares, resulting in a transaction amount of 52.78 million yuan [1]. Trading Information - On October 15, the net outflow of main funds was 577.95 thousand yuan, accounting for 10.95% of the total transaction amount [1][3]. - The net outflow of retail funds was 265.48 thousand yuan, representing 5.03% of the total transaction amount [1]. Company Announcement - Jinhao Medical announced the postponement of its second extraordinary general meeting originally scheduled for October 27, 2025, to October 28, 2025. The online voting period has been adjusted accordingly [1][3]. - The company expressed apologies for any inconvenience caused by the postponement and thanked investors for their understanding and support [1].

《关于2025年第二次临时股东会延期公告》 截至2025年10月15日收盘，锦好医疗（920925）报收于34.05元，较前一交易日下跌3.81%，最新总市值 为33.53亿元。该股当日开盘35.71元，最高35.71元，最低34.01元，成交额达5277.89万元，换手率为 2.78%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 公司于近日发布公告称，原定于2025年10月27日15:00召开的2025年第二次临时股东会现场会议，因工 作安排需要，经研究决定延期至2025年10月28日15:00召开。网络投票时间相应调整为2025年10月27日 15:00至10月28日15:00。股权登记日、会议地点、召开方式、审议事项及登记方式等其他事项不变。本 次延期符合相关法律法规及公司章程规定。公司对延期带来的不便表示歉意，并感谢投资者的理解与支 持。 最新公告列表 ...

Summary of Key Points Core Viewpoint The trading activity on the Beijing Stock Exchange (BSE) showed a significant decrease in transaction volume and value on September 26, with a total trading volume of 799 million shares and a transaction value of 19.456 billion yuan, down by 1.469 billion yuan compared to the previous trading day. Despite this decline, 80 stocks closed higher, indicating some resilience in the market. Trading Activity - The total trading volume on the BSE was 799 million shares, with a transaction value of 19.456 billion yuan, reflecting a decrease of 1.469 billion yuan from the previous day [1]. - Among the traded stocks, 80 closed higher, accounting for 28.99% of the total tradable stocks [1]. - The stocks with the highest closing gains included Jinhua New Materials (up 29.98%), Wuxin Tunnel Equipment (up 7.98%), and Silane Technology (up 7.54%) [1][2]. - Conversely, 193 stocks closed lower, with Jinhao Medical leading the declines at 11.00% [1]. Stock Performance - Jinhua New Materials had the highest trading volume at 1.158 billion yuan and a turnover rate of 74.80% [1]. - Other notable stocks in terms of trading volume included Wuxin Tunnel Equipment (572.73 million yuan) and Naconoer (504.29 million yuan) [1]. - The trading activity showed that 15 stocks had a turnover rate exceeding 10%, with three stocks exceeding 20% [1]. Market Dynamics - The overall market sentiment was mixed, with a notable number of stocks experiencing significant price fluctuations [1][2]. - The trading data indicates a potential shift in investor sentiment, as evidenced by the number of stocks that experienced both gains and losses [1][2]. Conclusion The BSE experienced a decline in trading activity on September 26, yet a portion of stocks demonstrated resilience with notable gains. The market dynamics suggest a complex environment where investor sentiment may be shifting, warranting close observation of future trading patterns and stock performances [1][2].

Market Overview - On September 26, the medical device sector declined by 1.68%, with JinHao Medical leading the drop [1] - The Shanghai Composite Index closed at 3828.11, down 0.65%, while the Shenzhen Component Index closed at 13209.0, down 1.76% [1] Stock Performance - Notable gainers in the medical device sector included: - Xiangsheng Medical (688358) with a closing price of 32.90, up 9.30% [1] - ST Kelly (300326) with a closing price of 5.88, up 3.70% [1] - Shengxiang Biology (688289) with a closing price of 20.50, up 3.07% [1] - Conversely, JinHao Medical (872925) saw a significant decline of 11.00%, closing at 33.00 [2] - Other notable decliners included: - JiMin Health (603222) down 8.46% to 10.71 [2] - Sino Medical (688108) down 5.18% to 26.55 [2] Trading Volume and Capital Flow - The medical device sector experienced a net outflow of 621 million yuan from institutional investors, while retail investors saw a net inflow of 489 million yuan [2] - The trading volume for Xiangsheng Medical was 55,000 shares, with a transaction value of 177 million yuan [1] - The trading volume for ST Kelly was 182,000 shares, with a transaction value of 106 million yuan [1] Capital Inflow Analysis - Major stocks with net inflows from institutional investors included: - Yingke Medical (300677) with a net inflow of 87.8 million yuan [3] - Shengxiang Biology (688289) with a net inflow of 41.2 million yuan [3] - Stocks with significant net outflows from retail investors included: - Yingke Medical with a net outflow of 84.4 million yuan [3] - Shengxiang Biology with a net outflow of 21.8 million yuan [3]

今日可交易A股中，股价上涨的有1477只，占比27.22%，下跌的有3877只，占比71.45%，其中，涨停的 有52只，跌停的有9只。 沪指今日下跌0.01%，64股收盘价创历史新高。 今日收盘价创历史新高股一览 | 代码 | 简称 | 收盘价（元） | 日涨跌幅（%） | 所属行业 | | --- | --- | --- | --- | --- | | 688109 | 品茗科技 | 58.90 | 20.01 | 计算机 | | 688585 | 上纬新材 | 132.10 | 20.00 | 基础化工 | | 872925 | 锦好医疗 | 37.08 | 19.04 | 医药生物 | | 301326 | 捷邦科技 | 134.50 | 15.95 | 电子 | | 603312 | 西典新能 | 50.67 | 10.01 | 电力设备 | | 603040 | 新坐标 | 85.22 | 10.00 | 汽车 | | 603286 | 日盈电子 | 46.42 | 10.00 | 汽车 | | 603083 | 剑桥科技 | 124.87 | 10.00 | 通信 | | 000988 | 华工 ...

Market Overview - On September 25, the medical device sector rose by 1.07%, led by JinHao Medical, while the Shanghai Composite Index closed at 3853.3, down 0.01% [1] - The Shenzhen Component Index closed at 13445.9, up 0.67% [1] Top Performers - JinHao Medical (872925) closed at 37.08, up 19.04% with a trading volume of 70,300 shares and a transaction value of 262 million yuan [1] - YaKangHaoJing (301235) closed at 34.41, up 6.63% with a trading volume of 79,800 shares and a transaction value of 279 million yuan [1] - MaiRui Medical (300760) closed at 245.00, up 4.75% with a trading volume of 162,200 shares and a transaction value of 3.907 billion yuan [1] Underperformers - Rejing Bio (688068) closed at 173.65, down 7.19% with a trading volume of 42,400 shares and a transaction value of 767 million yuan [2] - KangZhong Medical (688607) closed at 29.40, down 6.87% with a trading volume of 36,400 shares and a transaction value of 11 million yuan [2] - BoXun Bio (836504) closed at 28.36, down 3.47% with a trading volume of 5,642 shares and a transaction value of 1.632 million yuan [2] Capital Flow - The medical device sector saw a net inflow of 207 million yuan from institutional investors, while retail investors experienced a net outflow of 381 million yuan [2][3] - Major stocks like MaiRui Medical had a net inflow of 278 million yuan from institutional investors, but a net outflow of 153 million yuan from retail investors [3] Summary of Individual Stocks - MaiRui Medical (300760) had a significant net inflow from institutional investors at 278 million yuan, while retail investors showed a net outflow of 125 million yuan [3] - DongFuLong (300171) saw a net inflow of 32 million yuan from institutional investors but a net outflow of 3.078 million yuan from retail investors [3] - ZhenDe Medical (603301) had a net inflow of 31 million yuan from institutional investors, with retail investors showing a net outflow of 22.88 million yuan [3]

Market Overview - On September 24, the medical device sector rose by 0.1% compared to the previous trading day, with Hualan Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3853.64, up 0.83%, while the Shenzhen Component Index closed at 13356.14, up 1.8% [1] Top Performers - Hualan Co., Ltd. (301093) closed at 44.74, up 10.20% with a trading volume of 120,900 shares and a transaction value of 526 million yuan [1] - Huitai Medical (688617) closed at 321.65, up 6.86% with a trading volume of 21,200 shares [1] - Jinhao Medical (872925) closed at 31.15, up 6.68% with a trading volume of 17,400 shares [1] Other Notable Stocks - Dongxing Medical (301290) closed at 27.96, up 5.35% with a trading volume of 34,600 shares [1] - Dabo Medical (002901) closed at 55.06, up 5.02% with a trading volume of 42,100 shares [1] - Maike Aodi (300341) closed at 18.79, up 4.97% with a trading volume of 373,300 shares [1] Fund Flow Analysis - The medical device sector experienced a net outflow of 12.47 million yuan from institutional investors, while retail investors saw a net inflow of 24.3 million yuan [2] - The overall fund flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors increased their positions [2] Individual Stock Fund Flow - Maike Aodi (300341) had a net inflow of 94.47 million yuan from institutional investors, but a net outflow of 85.20 million yuan from retail investors [3] - Huo Jing Biological (688068) saw a net inflow of 58.76 million yuan from institutional investors, with retail investors also withdrawing funds [3] - Dabo Medical (002901) had a net inflow of 33.73 million yuan from institutional investors, while retail investors experienced a net outflow [3]

惠州市锦好医疗科技股份有限公司 第三届董事会第十五次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 证券代码：872925 证券简称：锦好医疗 公告编号：2025-081 （一）审议通过《关于聘任公司副总经理的议案》 1.议案内容： 1.会议召开时间：2025 年 9 月 17 日 2.会议召开地点：公司会议室 5.会议主持人：王敏先生 6.会议列席人员：监事及高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开程序符合《公司法》、《公司章程》和《董事会议事规 则》的相关规定。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 董事王芳因工作原因缺席，委托董事王敏代为表决。 董事李忠轩因工作原因以通讯方式参与表决。 董事郑能恒因工作原因以通讯方式参与表决。 二、议案审议情况 3.会议召开方式：现场与通讯方式相结合 4.发出董事会会议通知的时间和方式：2025 年 9 月 16 日以书面方式发出 为具体 ...

证券代码：872925 证券简称：锦好医疗 公告编号：2025-082 惠州市锦好医疗科技股份有限公司 高级管理人员任命公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、高级管理人员任命的基本情况 根据《公司法》及《公司章程》等有关规定，惠州市锦好医疗科技股份有限公司（以 下简称"公司"）于 2025 年 9 月 17 日召开了第三届董事会第十五次会议，审议通过了《关 于聘任公司副总经理的议案》，上述议案表决结果：同意 7 票，反对 0 票，弃权 0 票。 聘任张亮先生为公司副总经理，任职期限至第三届董事会任期届满之日，自 2025 年 9 月 17 日起生效。该人员持有公司股份 0 股，占公司股本的 0%，不是失信联合惩戒 对象。 聘任袁金鹏先生为公司副总经理，任职期限至第三届董事会任期届满之日，自 2025 年 9 月 17 日起生效。该人员持有公司股份 0 股，占公司股本的 0%，不是失信联合惩戒 对象。 （上述人员简历详见附件） 二、合规性说明及影响 （一）人员变动的合规性说明 三、独立董 ...

证券代码：872925 证券简称：锦好医疗 公告编号：2025-080 惠州市锦好医疗科技股份有限公司 出售资产的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、交易概况 （一）基本情况 惠州市锦好医疗科技股份有限公司（以下简称"公司""锦好医疗"）位于惠 州市惠阳区平潭镇独石村塘背园村民小组的老厂房目前空置，为提升资产运行效 率，盘活存量资产，结合公司的战略发展规划，拟将上述老厂房的工业用地使用 权及地上厂房对外转让。2025 年 9 月 11 日，公司召开第三届董事会第十四次会 议，审议通过了《关于出售公司部分土地使用权及厂房的议案》，同意公司以 3,800.00 万元（不低于评估价值）的交易价格出售位于惠州市惠阳区平潭镇独石 村塘背园村民小组的工业用地使用权及地上厂房。 综上所述，本次交易未达到《上市公司重大资产重组管理办法》规定的重大 资产重组的相关标准，不构成重大资产重组。 为保障交易的合法公允，锦好医疗聘请广东启恒土地房地产资产评估规划咨 询有限公司对拟出售工业房地产进行评估。 （ ...